Home › Funds › Squadron Capital Management LLC › RLMD
Squadron Capital Management LLC position in RLMD
RELMADA THERAPEUTICS INC · Health Care
Squadron Capital Management LLC reported holding 7,350,000 shares of RLMD (RELMADA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$50.9M, representing 19.90% of its reported portfolio and ranking #1 among its reported holdings. Squadron Capital Management LLC has disclosed RLMD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's RLMD position evolved
Squadron Capital Management LLC first disclosed a stake in RLMD in Q4 2025 at 6,700,000 shares (US$32.4M). The position peaked in Q1 2026 at 8,474,571 shares, worth US$59.0M. Across 3 filings, Squadron Capital Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,350,000 shares valued at US$50.9M — a reduction of -1,124,571 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 6.70M | $32.36M | New |
| Q1 2026 | 8.47M | $58.98M | Add |
| Q2 2026 | 7.35M | $50.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLMD and 13F data
RLMD (RELMADA THERAPEUTICS INC) is a Health Care company. 76 other funds we track also report a position in RLMD — the largest reported positions include Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$44.2M), Jones Hill Capital LP (US$25.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLMD
- Venrock Adviser, LLC 6.84M sh · $47.36M · Q2 2026
- Spruce Street Capital LP 6.39M sh · $44.23M · Q2 2026
- Jones Hill Capital LP 3.66M sh · $25.29M · Q2 2026
- Ikarian Capital, LLC 2.15M sh · $14.87M · Q2 2026
- STEMPOINT CAPITAL LP 1.46M sh · $10.10M · Q2 2026
- Commodore Capital LP 1.43M sh · $9.86M · Q2 2026
- Sio Capital Management, LLC 1.00M sh · $6.94M · Q2 2026
- Opaleye Management Inc. 935.00K sh · $6.47M · Q2 2026
- Boxer Capital Management, LLC 842.11K sh · $5.83M · Q2 2026
- GREAT POINT PARTNERS LLC 842.11K sh · $5.83M · Q2 2026
- Knott David M Jr 451.00K sh · $3.12M · Q2 2026
- HighVista Strategies LLC 445.80K sh · $3.08M · Q2 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held RLMD?
Squadron Capital Management LLC has disclosed RLMD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Squadron Capital Management LLC's current position in RLMD?
As of Q2 2026, Squadron Capital Management LLC holds 7.35M shares of RLMD (RELMADA THERAPEUTICS INC), valued at $50.86M, representing 19.90% of its reported portfolio and ranking #1.
Has Squadron Capital Management LLC been buying or selling RLMD?
In the latest 13F filing (Q2 2026), Squadron Capital Management LLC reduced its position in RLMD. The position peaked in Q1 2026 at 8.47M shares.
Which other funds hold RLMD?
Other major institutional holders of RLMD include Venrock Adviser, LLC, Spruce Street Capital LP, Jones Hill Capital LP, among 76 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.